Valproate pregnancy prevention — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Advise urgent specialist review before pregnancy planning changes
Valproate is associated with serious teratogenic and neurodevelopmental risks. Pregnancy planning in patients taking valproate requires specialist review and risk minimisation measures. Abrupt discontinuation may cause seizures, while folic acid does not remove valproate-related risk.
Reference: MHRA Drug Safety Update; BNF